FDA Approved Drug Products with Therapeutic Equivalence Evaluations

The Orange Book, published by the U.S. Food and Drug Administration, identifies drug products approved for safety and effectiveness. It provides therapeutic equivalence evaluations for approved pharmaceuticals.

Use Cases

• Analyze therapeutic equivalence evaluations to compare bioequivalence between brand-name and generic drug products.
• Identify FDA-approved drug products based on safety and effectiveness under the Federal Food, Drug, and Cosmetic Act.
• Map drug product approvals to support regulatory compliance and market entry analysis.

Strengths

• Data originates from the authoritative U.S. Food and Drug Administration, ensuring regulatory accuracy.
• The dataset is actively maintained, with a last recorded update in July 2025.

Limitations

• Specific data structure details like row count, column names, and sample data are unavailable for assessment.
• The dataset is distributed in a ZIP file format, which may require additional extraction steps before use.

Provenance

Source

U.S. Department of Health & Human Services, Food and Drug Administration

Collection Method

Official regulatory publication by the FDA.

Freshness

Last updated on 2025-07-11.

Geography

United States